Aclaris Therapeutics to Participate in the SVB Leerink Virtual 11th Annual Global Healthcare Conference

Rhea-AI Summary

Aclaris Therapeutics, a clinical-stage biopharmaceutical company (NASDAQ: ACRS), announced that Dr. Neal Walker, its President and CEO, will join a fireside chat at the SVB Leerink Virtual 11th Annual Global Healthcare Conference on February 16, 2022, at 9:20 a.m. ET. Aclaris management will also be available for virtual one-on-one meetings that day. The fireside chat webcast can be accessed via the company's website and will be archived for 30 days. Aclaris focuses on developing novel treatments for immuno-inflammatory diseases, backed by a strong R&D pipeline.

WAYNE, Pa., Feb. 02, 2022 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced that Dr. Neal Walker, President and CEO of Aclaris, will participate in a fireside chat at the SVB Leerink Virtual 11th Annual Global Healthcare Conference on Wednesday, February 16, 2022 at 9:20 a.m. ET. Management will be available February 16th throughout the day for virtual 1x1 meetings.

A webcast of the fireside chat may be accessed through the “Events” page of the “Investors” section of Aclaris’ website, www.aclaristx.com. The webcast will be archived for at least 30 days on the Aclaris website.

About Aclaris Therapeutics, Inc.

Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates to address the needs of patients with immuno-inflammatory diseases who lack satisfactory treatment options. The company has a multi-stage portfolio of drug candidates powered by a robust R&D engine exploring protein kinase regulation. For additional information, please visit www.aclaristx.com.

Aclaris Contact

investors@aclaristx.com

FAQ

What is the date for Aclaris Therapeutics' participation in the SVB Leerink Conference?

Aclaris Therapeutics will participate in the SVB Leerink Virtual 11th Annual Global Healthcare Conference on February 16, 2022.

Who is representing Aclaris Therapeutics at the healthcare conference?

Dr. Neal Walker, President and CEO of Aclaris Therapeutics, will represent the company at the conference.

What time is the fireside chat featuring Aclaris Therapeutics?

The fireside chat with Dr. Neal Walker will take place at 9:20 a.m. ET on February 16, 2022.

Where can I access the webcast of Aclaris Therapeutics' fireside chat?

The webcast of the fireside chat can be accessed on the 'Events' page in the 'Investors' section of Aclaris' website.

Will the Aclaris Therapeutics fireside chat be available after the live event?

Yes, the webcast will be archived for at least 30 days on Aclaris' website.